#ash22 — Public Fediverse posts

It was an honor to be the keynote speaker for the Women in Hematology reception at the American Society of Hematology meeting last night talking about how we honor ourselves and our values as we build careers that support our lives. #ash22

As #ASH22 winds down, the meeting hashtag is poised to surpass 250M impressions easy-peasy!

Looking forward to continued #learning, #frentorship, #fASHion, #PathAtASH #AKUatASH #networking and #science at #ASH23

cc: @[email protected] @[email protected] @[email protected] @[email protected] @[email protected]

Incredible to see continuously trending #ASH22 and related hashtags across chats/conferences/diseases/other categories! Stoked to see #lymsm #mmsm #leusm #cardiacpath #path2path #meded #lymphoma in the mix too!

Had the wonderful opportunity to get a quick hello in with fellow @[email protected] alums @[email protected] @[email protected] @[email protected] & @[email protected] - So inspired by these wonderful people!! 🇵🇰🇺🇸

Hoping to continue this great tradition of #AKUatASH for years to come! #ASH22

And the incredible experience of meeting new friends from across the world, continues! #ASH22 it was great to meet you, @[email protected]!

I feel like we need to have an @[email protected] alumni hangout and picture every year at the @[email protected] annual meeting! What say you @[email protected] @[email protected] @[email protected] (tag others please) - I am having too much FOMO of others hanging out with y’all! #AKUatASH #ASH22

With our incredible @[email protected] fellow team at #ASH22 - honored to be a small part of the education journey of these incredible folks! #PathAtASH

(please tag anyone I missed)

#ASH22 Don’t miss this live (oral abstracts) presentation by @[email protected] representing @[email protected] and our collaborative team!

Liquid Bx-based NGS is an alternative to tissue molecular profiling of #lymsm #mmsm and #leusm neoplasms!

🕐10:45 AM
📍ENMCC-208-210
📝Paper 498

#fASHion at #ASH22 (cc: @[email protected])

Reppin’ H&E and Giemsa colors in my tie today #PathAtash #hemepath

Normal bone marrow cells - what a joy to see!

Good morning, #NewOrleans!

As we enter Day 2 of #ASH22🩸Symplur data boasts >140M impressions and #1 trending conference hashtag! Have a great day y'all!

cc: @[email protected] @[email protected] @[email protected] @[email protected] @[email protected] @[email protected] @[email protected] @[email protected]

Festive airport season is the best season!

Ready to represent #PathAtASH #hemepath at #ASH22

See y’all soon!

About to start my journey to #ASH22 and even my T-shirt is looking forward to trip #2 to New Orleans this academic year! #USCAP23 will be next!! #PathAtASH #fASHion

NoLa definitely did something right to get SO MANY conferences!

Recent studies have shown that #AcuteMyeloidLeukemia favors #OxPhos metabolism. This #ASH22 abstract from my colleagues demonstrates with in vitro and in vivo models that the use of #ammocidin, an inhibitor of electron transport chain complex V, works synergistically with low-dose #venetoclax to kill #AML cells. Stop by poster 2652 or read more about it here: https://ashpublications.org/blood/article/140/Supplement%201/5959/492144/Electron-Transport-Chain-Complex-V-Inhibition #leukemia #cancer #oncology #hematology #hemonc #science #medicine

One of my lab colleagues will present a #metabolism-heavy study at the upcoming #ASH22 conference: we found that #leukemia can become resistant to BET-inhibition by using #lactate, often thought of as a metabolic byproduct, to keep their metabolism going. We also show that simultaneous BETi and inhibition of lactate-driven metabolism can reduce leukemic engraftment in animal models with both cell lines and primary samples: https://ash.confex.com/ash/2022/webprogram/Paper164701.html #science #medicine #hematology #oncology

Lots of abstracts today! Here's our own abstract to #ASH22. One question in #ClonalHematopoiesis is whether cells with a #muation are more inflammatory at baseline or are simply more reactive to stimuli. Here, we use #CRISPR to knock-in the DNMT3A p.R882H hotspot mutation into hematopoietic stem cells and differentiate into monocytes. #Transcriptome profiling shows that the mutant cells have activated myeloid signatures even without stim: https://ash.confex.com/ash/2022/webprogram/Paper170803.html #Genomics #Hematology #RNAseq